Personal profile
Personal profile
Dr. Park started his research career in the area of eukaryotic gene regulation through earning a Ph.D. degree at Rutgers, The State University of New Jersey, USA. He investigated a critical epigenetic enzyme complex in cancer development at Princeton University, USA as a postdoctoral researcher, and published highly cited articles in several premier journals. He also worked at the biochemistry laboratory of The Rockefeller University, New York, USA, and investigated p53 tumor suppressor with Professor Robert Roeder who is a founder of eukaryotic transcription studies.Dr. Park was appointed as a Senior Lecturer (comparable to a tenured Associate Professor in the American system) in 2009 at Massey University, a National University of New Zealand, and kept served as an academic faculty in the subject area of Biochemistry and Genetics. For over ten years at Massey University, his research had been driven mainly by undergraduate students and resulted in many peer-reviewed publications in the basic biomedical research area. His research was stably funded by several funding bodies including Genesis Oncology Trust and Health Research Council of New Zealand.He is collaborating with New Zealand biomedical research institutes including Hopkirk Research Institute for cancer vaccine development and Gillies McCindoe Research Institute for cancer stem cell research. Starting from 2020, he was appointed as a Senior Associate Professor at XJTLU as well as an Honorary Research Associate at Massey University. His group will investigate a novel epigenetic protein complex in cancer immune evasion and nanofibre-based cancer diagnostics and therapeutics.
Research interests
Characterisation of epigenetic factors in the immune evasion
Development of Nanofiber chromatin-based diagnostics
Experience
Senior Associate Professor - Deparment of Biological Sciences, XJTLU - 2000 to present
Senior Lecturer - School of Fundamental Sciences, Massey University, New Zealand - 2009 to 2020
Senior Research Associate - The Rockefeller University, USA
Postdoctoral Researcher - Department of Molecular Biology, Princeton University, USA
Teaching
BIO103 Molecular and Cell Biology
BIO207 Proteins in Action
BIO204 Advanced Genetics
BIO303 Final Year Project
Education/Academic qualification
PhD, Rutgers, The State University of New Jersey, USA
MSc, Korea Advanced Institute of Science and Technology (KAIST), Korea
BA, Korea University, Korea
Research areas
- Chromatin modification by CRISPR-mediated coactivator targeting in cancer and aging
- Chromatin-based intracellular and transdermal drug delivery
- Epigenetic and Signaling Rejuvenation: SIRT6-IGF-1-SNARE pathway
Person Types
- Staff
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 3 Finished
-
Suzhou Municipal Key Lab for Metabolic Syndrome Drug Research
Meng, J. (PI), Meng, W. (Team member), Jiang, X. (Team member), Wei, Z. (Team member), Li, T. (Team member), Liu, X. (Team member), Su, J. (Team member), Yue, C. (Team member), Douroudis, K. (Team member), Kappes, F. (Team member), Park, J. (Team member), Wang, M. (Team member), Rong, R. (Team member), Raju, S. (Team member), Huang, X. (Team member), Kadowaki, T. (Team member), OConnor, D. (Team member), Lu, Z. (Team member), Feng, Q. (Team member), Yi, Y. (Team member), Chen, Y. (Team member), Jiang, B. (Team member), Yuan, X. (Team member), Cui, J. (Team member), Meng, S. (Team member), Smith, G. (Team member), Loh, B. (Team member) & 李荪 (Team member)
1/01/22 → 31/12/23
Project: Governmental Research Project
-
Early diagnosis and clinical intervention of lung cancer
Park, J. (PI)
1/03/21 → 28/02/25
Project: Internal Research Project
-
XJTLU Wisdom Lake Macro-molecular Characterization Analysis Center
Lu, Z. (Team member), Han, G. (Team member), Kappes, F. (Team member), Park, J. (Team member), Meng, J. (Team member), Wang, R. (Team member), Yue, C. (Team member), Liu, X. (Team member), Sacitharan, P. (Team member), Jiang, J. (Team member), Wu, J. (Team member), Feng, Q. (Team member), Sun, J. (Team member), Chen, Y. (Team member), Li, T. (Team member), Jiang, B. (Team member), Li, W. (Team member), Qi, M. (Team member), Yi, Y. (Team member), O', D. (Team member), Li, M. (Team member), Zhao, C. (Team member), Carrillo, D. (Team member), Fu, L. (PI) & Wang, M. (Team member)
1/11/20 → 31/10/23
Project: Governmental Research Project
-
Enhanced cellular and transdermal delivery of the modified chromatin using gH625 cell-penetrating peptide
Zhang, X., Liang, Y., Zonta, F. & Park, J. H., Jan 2026, In: Nanomedicine: Nanotechnology, Biology, and Medicine. 71, 102884.Research output: Contribution to journal › Article › peer-review
-
Structural and functional insights into an anticancer peptide candidate derived from the EP400NL C-terminal domain
Liang, Y., Wang, Y., Sam, S., Li, Z., Khan, F. I. & Park, J. H., 9 Jul 2026, In: Biochemical and Biophysical Research Communications. 821, 153880.Research output: Contribution to journal › Article › peer-review
-
Enhanced cellular and transdermal delivery of the modified chromatin using cell-penetrating peptide display
Park, J. H., Zhang, X. & Liang, Y., 2025, DiscoverBMB Abstracts Proceedings.Research output: Chapter in Book or Report/Conference proceeding › Conference Proceeding
Open Access -
The multiple arrays of a PD1-derived peptide on chromatin specifically bind to PD-L1 and induce doxorubicin resistance in cancer cell lines
Zhang, X., Liu, Z., Guang, Y., Jiang, B. & Park, J. H., 5 Feb 2024, In: Biochemical and Biophysical Research Communications. 695, 149435.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
EP400NL is involved in PD-L1 gene activation by forming a transcriptional coactivator complex
Li, Z., Kim, H., Kim, J. & Park, J. H., Mar 2023, In: Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 1866, 1, 194889.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus)
Activities
-
Springer Nature (Publisher)
Park, J. (Reviewer)
17 Dec 2025 → 30 Dec 2025Activity: Peer-review and editorial work of publications › Publication Peer-review
-
Sunset SoundScapes
Baek, M. J. (Organiser), Park, J. (Participant), Lee, J. H. (Participant), Lee, E. (Participant), Seong, M. (Participant), Md Rian, I. (Participant), Essen, I. (Participant), Longo, G. (Participant), Song, Y. (Participant), Taylor, D. (Participant), Schnabel, M. A. (Participant), Dall'Asta, J. C. (Participant) & Han, J. (Participant)
5 Dec 2025Activity: Participating in or organising an event › Participating in an event e.g. a conference, workshop, …
-
Springer Nature (Publisher)
Park, J. (Reviewer)
10 Aug 2025 → 19 Nov 2025Activity: Peer-review and editorial work of publications › Publication Peer-review
-
Chromatin-based Transdermal Delivery for Cosmetics and Biomedical Application
Park, J. (Speaker)
24 May 2025Activity: Talk or presentation › Invited talk
-
MSK1/2 in cancer and neurodegeneration
Park, J. (Speaker)
22 Apr 2025Activity: Talk or presentation › Invited talk